- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03745976
Questionnaire and Radiography for Prosthesis Follow-up (Follow-up)
Evaluation of a New Long-term Total Articular Prosthesis Follow-up Strategy by Simple Questionnaire and Radiography
Ever-evolving prosthetic activity as described in a Swedish study that predicts 469 TKA per 10,000 inhabitants in 2130. Increased consultation of controls and post-arthroplasty follow-up is expected. There is a legal obligation to ensure long-term follow-up without official recommendation on follow-up procedures. The objective is to compare a consultation + Xray by the surgeon versus an Xray and a questionnaire completed by the patient who had a knee or hip replacement. This is to demonstrate the equivalence of both.
All patients who come back for an annual check of a prosthesis should complete this questionnaire and perform an X-ray of their prosthesis. The study lasts one year and includes all the patients with a previous knee or hip arthroplasty.
The result of the questionnaire and Xray will be compared to that of the consultation and Xray.
Study Overview
Status
Intervention / Treatment
Detailed Description
An english study published an article showing that a follow up by questionnaire versus a consultation was also effective.
For this study, investigator is going to take back all the patients having to return to consultation in 2017. . Normally at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
Thus investigator will be able to see the number of patients seen in consultation compared to the theoretical number The purpose of this study is to highlight the non-inferiority of the questionnaire compared to the consultation for screening for complications at 10 years.
If this proves to be the case, only complicating patients could be reviewed by calling them to the radio and their questionnaire.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63003
- CHU Clermont-Ferrand
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who have had a primary total hip or total knee arthroplasty that must be seen again in 2017. Normally at 3 months, 1 years, 3, 5, 10, 15 and 20 years post-operatively
Exclusion Criteria:
- Patients who have previous complications with their joint replacement
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1
a new long-term total articular prosthesis follow-up strategy by simple questionnaire and radiography (questionnaire and Xray for all patients)
|
questionnaire and Xray for all patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 3 months
|
Feasibility study of a new strategy of follow-up by questionnaire
|
at 3 months
|
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 1year
|
Feasibility study of a new strategy of follow-up by questionnaire
|
at 1year
|
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 3 years
|
Feasibility study of a new strategy of follow-up by questionnaire
|
at 3 years
|
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 5 years
|
Feasibility study of a new strategy of follow-up by questionnaire
|
at 5 years
|
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 10 years
|
Feasibility study of a new strategy of follow-up by questionnaire
|
at 10 years
|
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 15 years
|
Feasibility study of a new strategy of follow-up by questionnaire
|
at 15 years
|
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 20 years
|
Feasibility study of a new strategy of follow-up by questionnaire
|
at 20 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
economic impact (Number of working day)
Time Frame: at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
|
Number of working day in days
|
at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
|
economic impact (Number of consultations)
Time Frame: at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
|
Number of consultations with the surgeon,
|
at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
|
economic impact (Number of radiography)
Time Frame: at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
|
Number of radiography realized by the patient
|
at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
|
economic impact (Cost phone call)
Time Frame: at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
|
According to the number of realized phone call
|
at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
|
Evaluation of the feasibility of the questionnaire for detection of certain complications
Time Frame: at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
|
Evaluation of the feasibility of the questionnaire method
|
at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Roger ERIVAN, University Hospital, Clermont-Ferrand
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CHU-412
- 2018-A01022-53 (Other Identifier: 2018-A01022-53)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip and Knee Arthroplasties
-
Molnlycke Health Care ABCompletedArthroplasties, Hip Replacement | Arthroplasties, Knee ReplacementUnited States
-
Hospital District of Helsinki and UusimaaUniversity of Turku; Karlstad UniversityCompletedArthroplasties, Hip Replacement | Arthroplasties, Knee ReplacementFinland
-
Stryker South PacificCompletedKnee Replacement | Arthroplasties
-
Smith & Nephew, Inc.TerminatedArthroplasties, Hip ReplacementUnited States, Belgium, Canada
-
University of AarhusEnrolling by invitationArthroplasties, Hip ReplacementDenmark
-
CorinActive, not recruitingArthroplasties, Knee ReplacementUnited States
-
Washington University School of MedicineStryker NordicCompletedArthroplasties, Knee ReplacementUnited States
-
Stryker South PacificCompletedArthroplasties, Replacement, Knee
-
University of Colorado, DenverNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Recruiting
-
Stryker South PacificCompletedArthroplasties, Replacement, Knee
Clinical Trials on questionnaire and Xray for all patients
-
Hospices Civils de LyonRecruitingAdvanced Cancer | Sexual SatisfactionFrance
-
Stanford UniversityBass Center Leukemia Pilot Grant; Pediatric Oncology Experimental Therapeutics...Not yet recruitingOutcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available ImmunotherapyLymphoid LeukemiaUnited States
-
ElsanCompletedNeuropathic PainFrance
-
Jens Rikardt AndersenCompleted
-
Hospices Civils de LyonCompleted
-
Nantes University HospitalMILDTCompletedPathological or "at Risk" GamblingFrance
-
Centre Hospitalier Universitaire de BesanconDirection Générale de l'Offre de SoinsNot yet recruiting
-
King Fahad Medical CityUnknown
-
The First Affiliated Hospital of Zhengzhou UniversityBeiGeneRecruiting
-
Cancer Institute and Hospital, Chinese Academy...Beijing Huanxing Cancer Hospital; Cancer Hospital, Chinese Academy of Medical...RecruitingEarly-stage Breast CancerChina